Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

Pharma major GSK (LSE: GSK) on Tuesday said its urinary tract infection treatment gepotidacin, under the brand name Blujepa, ...

Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...

ChatGPT's recommended these four FTSE 100 titans as the best stocks to buy for a second income, but are they actually good ...

Second, the threat of tariffs imposed on the USA’s allies is already causing retaliatory measures, including the potential ...

The four-pronged strategy begins with the acquisition of GSK's oncology portfolio, which includes all of its marketed products and late-stage candidates, for $14.5 billion, with a further $1.5 ...

Value stocks offer good opportunities for long-term investment in 2025, especially for investors who want stability and growth. Value stocks usually have lower ...

Most of this spent is out of the pocket. By providing a big portfolio of 140 products with a relative low price, GSK is winning the game of "volume" in the market. This large portfolio also gives ...

GSK claims to investors that its decision ... Provide specific products and services to you, such as portfolio management or data aggregation. Develop and improve features of our offerings.

GSK is a world leader in vaccines and has a broad portfolio targeting diseases such as shingles, meningitis, and influenza. In pharmaceuticals, it develops treatments for conditions including ...

But don’t see the crash as a buying opportunity, or as a selling opportunity either. Take it as a reminder that your stock ...